CASI Pharmaceuticals (CASI) Stock: Gaining On Priority Review

CASI Pharmaceuticals Inc (NASDAQ: CASI) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced a key update with regard to bringing a pipeline product to market. Of course, the update led to excitement among investors, sending the stock toward the top and prompting an alert … Read more

CASI Pharmaceuticals (CASI) Climbs On Orphan Drug Designation

CASI Pharmaceuticals, Inc. (NASDAQ: CASI) CASI Pharmaceuticals is having an incredible day in the market today after announcing that it has received Orphan Drug Designation from the European Medicines Agency for it’s primary drug candidate. Today, we’ll talk about the candidate and the Orphan Drug Designation, what we’ve seen in the market today as a … Read more